Difference between revisions of "PTEN"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 53: | Line 53: | ||
cell survival signaling. | cell survival signaling. | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase interaction partners|*]] | [[Category:Tissue transglutaminase interaction partners|*]] | ||
Latest revision as of 12:24, 10 March 2015
| PTEN | |
|---|---|
| Substrate peptide name | PTEN - Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and
dual-specificity protein phosphatase |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P60484 |
| Interacting residues | Not determined yet |
| Interacting sequence | Not determined yet |
| TG2 Swissprot ID | P21980 |
| Interacting residues of TG2 | Not determined yet |
| Interacting sequence of TG2 | Not determined yet |
| Structure | 1D5R |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:18381937 |
| Notes | TG2 promotes the hypophosphorilation and degradation of PTEN by ubiquitin-proteasomal
pathway and results in constitutive activation of focal adhesion kinase/AKT cell survival signaling. |
